Drexler et al. (2024) identified a neural-lineage epigenetic signature in high-grade glioma in which hypomethylation of neuronal genes correlated with poorer survival in IDH-wildtype glioblastoma, indicating the prognostic relevance of lineage-associated methylation programs [20]. The gene discussed is IDH2; the disease is central nervous system cancer.